Hello fellow holders,
I hope you're all having a nice day so far.
Sorry to start yet another thread, but I wanted to do so in case some holders were to miss this post amidst the ongoing previous thread.
I've receieved some clarification from R. Hopkins today regarding the timeline of expected news regarding maiden revenues for Zelira, and the insomnia trial report. Please find these below.Expected 2020 Newsflow Jan-June
- Insomnia phase II trial results (in the next fortnight). "The Sleep Team overseeing the trial have confirmed they’re on-track to report the data in the second half of Feb. Almost there."
- Quarterly report detailing maiden revenues. "We were very pleased to report our first licensing deal for HOPE late last year. Revenues will be recorded in Q1 of 2020 and reported in the quarterly scheduled for release in April, 2020."
Wishing you all the best,
Harry E.
Clarification from R. Hopkins on Insomnia & Maiden Revenues timeline
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.055(12.4%) |
Mkt cap ! $4.425M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 42.0¢ | 38.0¢ | $6.402K | 15.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3880 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 361 | 1 |
View Market Depth
| Last trade - 15.51pm 09/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |